首页> 外文期刊>PACE: Pacing and clinical electrophysiology >Reducing unnecessary right ventricular pacing with the managed ventricular pacing mode in patients with sinus node disease and AV block.
【24h】

Reducing unnecessary right ventricular pacing with the managed ventricular pacing mode in patients with sinus node disease and AV block.

机译:在窦房结疾病和房室传导阻滞患者中,通过有控制的心室起搏模式减少不必要的右心室起搏。

获取原文
获取原文并翻译 | 示例
           

摘要

BACKGROUND: Frequent and unnecessary right ventricular apical pacing increases the risk of atrial fibrillation or congestive heart failure. We evaluated a new pacing algorithm, managed ventricular pacing (MVP) which automatically changes modes between AAI/R and DDD/R in patients receiving pacemakers for symptomatic bradycardia. METHODS: Patients were randomized to the MVP mode or DDD/R mode for 1 month and then crossed over to the alternate pacing modality for an additional month. On completion of the crossover phase, the pacing mode selected was individualized and patients were followed for an additional 4 months. RESULTS: Of the 129 patients who successfully completed the crossover study, the cumulative percent ventricular pacing was significantly reduced in the MVP mode (median 1.4%) compared to the DDD/R mode (median 89.6%, 94.0% relative reduction; 95% CI 89.3-98.8%, P < 0.001). Patients with sinus node disease (SND, n = 51) when compared to patients with AV block (AVB) (n = 68) experienced a greater reduction in ventricular pacing with the MVP mode compared to the DDD/R mode (median relative reduction 99.1%; 95% CI 97.5-99.9% vs median relative reduction 60.1%; 95% CI 16.7-93.9% P < 0.001). The reduced percent ventricular pacing during MVP was sustained over longer term follow-up. CONCLUSIONS: The majority of patients with a bradycardia indication for cardiac pacing do not require ventricular pacing most of the time. The MVP mode significantly reduces unnecessary right ventricular pacing. This mode benefits even patients with intermittent AVB and is sustained over longer term follow-up.
机译:背景:频繁和不必要的右心室心律起搏增加了心房颤动或充血性心力衰竭的风险。我们评估了一种新的起搏算法,即有管理的心室起搏(MVP),该技术可在患有症状性心动过缓的起搏器患者中自动在AAI / R和DDD / R之间改变模式。方法:将患者随机分为MVP模式或DDD / R模式1个月,然后再过渡至另一种起搏模式另外1个月。在完成交叉阶段后,将选择的起搏模式进行个性化设置,并随访患者另外4个月。结果:在成功完成交叉研究的129例患者中,与DDD / R模式相比,MVP模式(中位数为1.4%)与累积心室起搏百分比显着降低(中位数为89.6%,相对减少为94.0%; CI为95%) 89.3-98.8%,P <0.001)。窦房结疾病(SND,n = 51)的患者与AV阻滞(AVB)(n = 68)的患者相比,MVP模式的心室起搏比DDD / R模式的患者更大(中位数相对减少99.1)百分比; 95%CI 97.5-99.9%,中位数相对减少60.1%; 95%CI 16.7-93.9%P <0.001)。 MVP期间降低的心室起搏百分比在长期随访中得以维持。结论:大多数有心动过缓迹象的心脏起搏患者大部分时间不需要心室起搏。 MVP模式可显着减少不必要的右心室起搏。这种模式甚至使间歇性AVB患者受益,并且可以长期随访。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号